Amy J. Armstrong

Targeting ROS in cancer: rationale and strategies

Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements

The Highly Recurrent PP2A Aα-Subunit Mutation P179R Alters Protein Structure and Impairs PP2A Enzyme Function to Promote Endometrial Tumorigenesis

Using a novel computational drug-repositioning approach (DrugPredict) to rapidly identify potent drug candidates for cancer treatment